Updated on 24 January 2013
Chemspec will manufacture Can-Fite's active pharmaceuticals ingredients (API)
Singapore: Israel-based Can-Fite BioPharma announced that the active pharmaceuticals ingredients (API) of CF101 and CF102 are up-scaled and manufactured by Chemspec, a leading Chinese CRO.
This will support the on-going advanced stage clinical trials conducted by the company with a more efficient and less costly procedure. It will also enable the company to supply API to its current and future strategic partners.
Survey Box
Subscribe to BioSpectrum Asia digital mag at an attractive price of US $49.99 a year
(Includes all 24 regular & special issues @ fortnightly frequency)
Send this article by email
Australia
China
India
Japan
Korea
Malaysia
New Zealand 
Singapore
Taiwan
Thailand
